2OBD - JenaLib

Asym./Biol. Unit - manually (Jmol Viewer)

Asym./Biol. Unit (Jmol Viewer)

Asym./Biol. Unit - sites (Jmol Viewer)

Title :   CRYSTAL STRUCTURE OF CHOLESTERYL ESTER TRANSFER PROTEIN

Authors :   X. Qiu

Date :   18 Dec 06 (Deposition) - 23 Jan 07 (Release) - 24 Feb 09 (Revision)

Method :   X-RAY DIFFRACTION

Resolution :   2.10

Chains :   Asym./Biol. Unit : A

Keywords :   Cholesteryl Ester, Lipid Transfer Protein, Lipid Transport (Keyword Search: [Gene Ontology, PubMed, Web (Google)] )

Reference :   X. Qiu, A. Mistry, M. J. Ammirati, B. A. Chrunyk, R. W. Clark, Y. Cong, J. S. Culp, D. E. Danley, T. B. Freeman, K. F. Geoghegan, M. C. Griffor, S. J. Hawrylik, C. M. Hayward, P. Hensley, L. R. Hoth, G. A. Karam, M. E. Lira, D. B. Lloyd, K. M. Mcgrath, K. J. Stutzman-Engwall, A. K. Subashi, T. A. Subashi, J. F. Thompson, I. K. Wang, H. Zhao, A. P. Seddon
Crystal Structure Of Cholesteryl Ester Transfer Protein Reveals A Long Tunnel And Four Bound Lipid Molecules.
Nat. Struct. Mol. Biol. V. 14 106 2007
PubMed-ID: 17237796 | Reference-DOI: 10.1038/NSMB1197
(for further references see the PDB file header)

Molecule 1 - CHOLESTERYL ESTER TRANSFER PROTEIN
	Chains	:	A
	Engineered	:	YES
	Expression System	:	CRICETULUS GRISEUS
	Expression System Cell Line	:	CHINESE HAMSTER OVARY DG44
	Expression System Common	:	CHINESE HAMSTER
	Expression System Taxid	:	10029
	Gene	:	CETP
	Mutation	:	YES
	Organism Common	:	HUMAN
	Organism Scientific	:	HOMO SAPIENS
	Organism Taxid	:	9606
	Synonym	:	LIPID TRANSFER PROTEIN I

		1
Asymmetric/Biological Unit	:	A

Summary Information (see also Sequences/Alignments below)

Asymmetric/Biological Unit (8, 12)

No.	Name	Count	Type	Full Name
1	1PE	2	Ligand/Ion	PENTAETHYLENE GLYCOL
2	2OB	2	Ligand/Ion	CHOLESTERYL OLEATE
3	CL	1	Ligand/Ion	CHLORIDE ION
4	EPE	1	Ligand/Ion	4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID
5	FU4	1	Ligand/Ion	2,6-ANHYDRO-1-DEOXY-D-GALACTITOL
6	NDG	2	Ligand/Ion	2-(ACETYLAMINO)-2-DEOXY-A-D-GLUCOPYRANOSE
7	PCW	2	Ligand/Ion	1,2-DIOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE
8	PG4	1	Ligand/Ion	TETRAETHYLENE GLYCOL

Asymmetric Unit (12, 12)

No.	Name	Evidence	Residues	Description
01	AC1	SOFTWARE	GLU A:399 , NDG A:482	BINDING SITE FOR RESIDUE NDG A 481
02	AC2	SOFTWARE	ASN A:396 , LEU A:397 , THR A:398 , GLU A:399 , SER A:401 , NDG A:481 , FU4 A:483	BINDING SITE FOR RESIDUE NDG A 482
03	AC3	SOFTWARE	SER A:401 , SER A:402 , GLU A:403 , NDG A:482 , HOH A:498 , HOH A:634	BINDING SITE FOR RESIDUE FU4 A 483
04	AC4	SOFTWARE	ARG A:158 , GLN A:388 , ILE A:389	BINDING SITE FOR RESIDUE CL A 493
05	AC5	SOFTWARE	ILE A:15 , VAL A:136 , VAL A:198 , GLN A:199 , ALA A:202 , LEU A:228 , SER A:230 , HIS A:232 , LEU A:261 , PHE A:263 , PHE A:441 , PHE A:461	BINDING SITE FOR RESIDUE 2OB A 485
06	AC6	SOFTWARE	PHE A:292 , VAL A:321 , VAL A:323 , VAL A:340 , ILE A:367 , THR A:369 , TYR A:375 , VAL A:416 , GLY A:417 , VAL A:421 , MET A:422 , LEU A:425 , LEU A:457 , PCW A:488	BINDING SITE FOR RESIDUE 2OB A 486
07	AC7	SOFTWARE	LEU A:23 , THR A:27 , VAL A:74 , PHE A:197 , ARG A:201 , SER A:435 , GLY A:437 , PHE A:441 , LEU A:467 , HOH A:870	BINDING SITE FOR RESIDUE PCW A 487
08	AC8	SOFTWARE	LEU A:206 , ASP A:208 , PHE A:265 , LEU A:273 , GLY A:281 , ARG A:282 , LEU A:283 , MET A:284 , CYS A:325 , ILE A:331 , SER A:342 , ARG A:424 , LEU A:425 , VAL A:428 , PHE A:429 , 2OB A:486 , HOH A:607 , HOH A:757	BINDING SITE FOR RESIDUE PCW A 488
09	AC9	SOFTWARE	ASP A:114 , GLY A:314 , PHE A:315 , PRO A:316 , SER A:317	BINDING SITE FOR RESIDUE EPE A 489
10	BC1	SOFTWARE	HIS A:60 , LYS A:98 , SER A:112	BINDING SITE FOR RESIDUE 1PE A 490
11	BC2	SOFTWARE	TRP A:106 , THR A:298 , LEU A:384 , HOH A:590 , HOH A:741 , HOH A:771	BINDING SITE FOR RESIDUE 1PE A 491
12	BC3	SOFTWARE	ALA A:131 , LEU A:217 , THR A:218 , GLY A:219 , ASP A:220 , HOH A:784 , HOH A:817	BINDING SITE FOR RESIDUE PG4 A 492

Asymmetric/Biological Unit

No.	Residues
1	A:143	-	A:184

Asymmetric/Biological Unit

No.	Residues
1	Val A:312	-	Gly A:313

Asymmetric/Biological Unit (11, 11)

								dbSNP	PDB
No.	Source	Variant ID	Variant			UniProt ID	Status	ID	Chain	Variant
01	UniProt	VAR_033098	R	154	W	CETP_HUMAN	Polymorphism	34716057	A	R	137	W
02	UniProt	VAR_033099	L	168	P	CETP_HUMAN	Disease (HALP1)	---	A	L	151	P
03	UniProt	VAR_033100	R	299	C	CETP_HUMAN	Disease (HALP1)	142459781	A	R	282	C
04	UniProt	VAR_013919	G	331	S	CETP_HUMAN	Polymorphism	5881	A	G	314	S
05	UniProt	VAR_017019	V	385	M	CETP_HUMAN	Polymorphism	34855278	A	V	368	M
06	UniProt	VAR_013920	A	390	P	CETP_HUMAN	Polymorphism	5880	A	A	373	P
07	UniProt	VAR_013921	V	422	I	CETP_HUMAN	Polymorphism	5882	A	I	405	I
08	UniProt	VAR_031127	V	455	M	CETP_HUMAN	Polymorphism	2228667	A	V	438	M
09	UniProt	VAR_004172	D	459	G	CETP_HUMAN	Disease (HALP1)	2303790	A	D	442	G
10	UniProt	VAR_013922	R	468	Q	CETP_HUMAN	Polymorphism	1800777	A	R	451	Q
11	UniProt	VAR_013923	V	486	M	CETP_HUMAN	Polymorphism	5887	A	V	469	M

SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

Asymmetric/Biological Unit (1, 1)

	PROSITE			UniProtKB		PDB
No.	ID	AC	Description	ID	Location	Count	Location
1	LBP_BPI_CETP	PS00400	LBP / BPI / CETP family signature.	CETP_HUMAN	26-58	1	A:9-41

Asymmetric/Biological Unit (16, 16)

	ENSEMBL					UniProtKB			PDB
No.	Transcript ID	Exon	Exon ID	Genome Location	Length	ID	Location	Length	Count	Location	Length
1.1a	ENST00000200676	1a	ENSE00001820497	chr16:56995762-56996009	248	CETP_HUMAN	1-40	40	1	A:5-23	19
1.2	ENST00000200676	2	ENSE00001108758	chr16:56996922-56997036	115	CETP_HUMAN	40-78	39	1	A:23-61	39
1.3	ENST00000200676	3	ENSE00000685107	chr16:57003298-57003432	135	CETP_HUMAN	78-123	46	1	A:61-106	46
1.4	ENST00000200676	4	ENSE00000685106	chr16:57003523-57003593	71	CETP_HUMAN	123-147	25	1	A:106-130	25
1.5	ENST00000200676	5	ENSE00000685105	chr16:57003826-57003913	88	CETP_HUMAN	147-176	30	1	A:130-159	30
1.6	ENST00000200676	6	ENSE00000685103	chr16:57004945-57005014	70	CETP_HUMAN	176-199	24	1	A:159-182	24
1.7	ENST00000200676	7	ENSE00000685102	chr16:57005233-57005293	61	CETP_HUMAN	200-220	21	1	A:183-203	21
1.8	ENST00000200676	8	ENSE00000685101	chr16:57005904-57005995	92	CETP_HUMAN	220-250	31	1	A:203-233	31
1.9	ENST00000200676	9	ENSE00000685100	chr16:57007243-57007422	180	CETP_HUMAN	251-310	60	1	A:234-293	60
1.10	ENST00000200676	10	ENSE00000685099	chr16:57009013-57009063	51	CETP_HUMAN	311-327	17	1	A:294-310	17
1.11	ENST00000200676	11	ENSE00000685096	chr16:57012003-57012167	165	CETP_HUMAN	328-382	55	1	A:311-365	55
1.12	ENST00000200676	12	ENSE00000685095	chr16:57015070-57015137	68	CETP_HUMAN	383-405	23	1	A:366-388	23
1.13	ENST00000200676	13	ENSE00000685094	chr16:57015559-57015592	34	CETP_HUMAN	405-416	12	1	A:388-399	12
1.14	ENST00000200676	14	ENSE00000685093	chr16:57016077-57016149	73	CETP_HUMAN	417-441	25	1	A:400-424	25
1.15	ENST00000200676	15	ENSE00000685092	chr16:57017238-57017323	86	CETP_HUMAN	441-469	29	1	A:424-452	29
1.16b	ENST00000200676	16b	ENSE00001925693	chr16:57017504-57017757	254	CETP_HUMAN	470-493	24	1	A:453-476	24

Asymmetric/Biological Unit

Reformat:	Number of residues per line = ('0' or empty: single-line sequence representation)
	Number of residues per labelling interval =
	UniProt sequence: complete aligned part

Show mapping:	SCOP domains	CATH domains	Pfam domains	Secondary structure (by author)
	SAPs(SNPs)	PROSITE motifs	Exons
	(details for a mapped element are shown in a popup box when the mouse pointer rests over it)

Chain A from PDB  Type:PROTEIN  Length:472
 aligned with CETP_HUMAN | P11597 from UniProtKB/Swiss-Prot  Length:493

    Alignment length:472
                                    31        41        51        61        71        81        91       101       111       121       131       141       151       161       171       181       191       201       211       221       231       241       251       261       271       281       291       301       311       321       331       341       351       361       371       381       391       401       411       421       431       441       451       461       471       481       491  
           CETP_HUMAN    22 TSHEAGIVCRITKPALLVLNHETAKVIQTAFQRASYPDITGEKAMMLLGQVKYGLHNIQISHLSIASSQVELVEAKSIDVSIQNVSVVFKGTLKYGYTTAWWLGIDQSIDFEIDSAIDLQINTQLTCDSGRVRTDAPDCYLSFHKLLLHLQGEREPGWIKQLFTNFISFTLKLVLKGQICKEINVISNIMADFVQTRAASILSDGDIGVDISLTGDPVITASYLESHHKGHFIYKNVSEDLPLPTFSPTLLGDSRMLYFWFSERVFHSLAKVAFQDGRLMLSLMGDEFKAVLETWGFNTNQEIFQEVVGGFPSQAQVTVHCLKMPKISCQNKGVVVNSSVMVKFLFPRPDQQHSVAYTFEEDIVTTVQASYSKKKLFLSLLDFQITPKTVSNLTESSSESVQSFLQSMITAVGIPEVMSRLEVVFTALMNSKGVSLFDIINPEIITRDGFLLLQMDFGFPEHLLVDFLQSLS 493
               SCOP domains ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- SCOP domains
               CATH domains ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- CATH domains
               Pfam domains --------------LBP_BPI_CETP-2obdA01 A:19-199                                                                                                                                                        --------------------------LBP_BPI_CETP_C-2obdA02 A:226-463                                                                                                                                                                                                              ------------- Pfam domains
         Sec.struct. author ..ee..eeeeeehhhhhhhh.hhhhhhhhhhhhh....eeeeeee...eeeeeeeeeeeeeeeeeeeeeeeee...eeeeeeeeeeeeeeeeeeeee..hhhhh..eeeeeeeeeeeeeeeeeeeeee..eeeeeeeeeeeeeeeeeeee.......hhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhh....eeee.......ee...eeeeee..eeee..........eehhhhh.....eeeeeehhhhhhhhhhhhhh...eeeehhhhhhhhhhhh.....hhhhhhhhh.hhhhheeeeee....eeeee..eeeeeeeeeeeee....hhhhh..eeeeeeeeeeeeeeee..eeeeeeeeeeeeeeeeee.....hhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhheeeeeeeeee..eeeeeeeee.hhhhhhhhhhh.. Sec.struct. author
                 SAPs(SNPs) ------------------------------------------------------------------------------------------------------------------------------------W-------------P----------------------------------------------------------------------------------------------------------------------------------C-------------------------------S-----------------------------------------------------M----P-------------------------------I--------------------------------M---G--------Q-----------------M------- SAPs(SNPs)
                    PROSITE ----LBP_BPI_CETP  PDB: A:9-41        --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- PROSITE
           Transcript 1 (1) Exon 1.1a          -------------------------------------Exon 1.3  PDB: A:61-106 UniProt: 78-123       -----------------------Exon 1.5  PDB: A:130-159      -----------------------Exon 1.7             ------------------------------Exon 1.9  PDB: A:234-293 UniProt: 251-310                   Exon 1.10        Exon 1.11  PDB: A:311-365 UniProt: 328-382             Exon 1.12              -----------Exon 1.14  PDB: A:400-424----------------------------Exon 1.16b               Transcript 1 (1)
           Transcript 1 (2) ------------------Exon 1.2  PDB: A:23-61 UniProt: 40-78  --------------------------------------------Exon 1.4  PDB: A:106-130 ----------------------------Exon 1.6  PDB: A:159-182--------------------Exon 1.8  PDB: A:203-233       ----------------------------------------------------------------------------------------------------------------------------------------------------------Exon 1.13   ------------------------Exon 1.15  PDB: A:424-452    ------------------------ Transcript 1 (2)
                 2obd A   5 TSHEAGIVCRITKPALLVLNHETAKVIQTAFQRASYPDITGEKAMMLLGQVKYGLHNIQISHLSIASSQVELVEAKSIDVSIQDVSVVFKGTLKYGYTTAWWLGIDQSIDFEIDSAIDLQINTQLTADSGRVRTDAPDCYLSFHKLLLHLQGEREPGWIKQLFTNFISFTLKLVLKGQICKEINVISNIMADFVQTRAASILSDGDIGVDISLTGDPVITASYLESHHKGHFIYKDVSEDLPLPTFSPTLLGDSRMLYFWFSERVFHSLAKVAFQDGRLMLSLMGDEFKAVLETWGFNTNQEIFQEVVGGFPSQAQVTVHCLKMPKISCQNKGVVVDSSVMVKFLFPRPDQQHSVAYTFEEDIVTTVQASYSKKKLFLSLLDFQITPKTVSNLTESSSESIQSFLQSMITAVGIPEVMSRLEVVFTALMNSKGVSLFDIINPEIITRDGFLLLQMDFGFPEHLLVDFLQSLS 476
                                    14        24        34        44        54        64        74        84        94       104       114       124       134       144       154       164       174       184       194       204       214       224       234       244       254       264       274       284       294       304       314       324       334       344       354       364       374       384       394       404       414       424       434       444       454       464       474

Legend:		→ Mismatch	(orange background)
	-	→ Gap	(green background, '-', border residues have a numbering label)
		→ Modified Residue	(blue background, lower-case, 'x' indicates undefined single-letter code, labelled with number + name)
	x	→ Chemical Group	(purple background, 'x', labelled with number + name, e.g. ACE or NH2)
	extra numbering lines below/above indicate numbering irregularities and modified residue names etc., number ends below/above '\|'

(no "SCOP Domain" information available for 2OBD)

(no "CATH Domain" information available for 2OBD)

Asymmetric/Biological Unit

Clans(

)

Families(

)

Organisms( (-)

)

Clan: no clan defined [family: LBP_BPI_CETP] (1)

Family: LBP_BPI_CETP (1)

Homo sapiens (Human) (1)

LBP_BPI_CETP-2obdA01

A:19-199

Clan: no clan defined [family: LBP_BPI_CETP_C] (1)

Family: LBP_BPI_CETP_C (1)

Homo sapiens (Human) (1)

LBP_BPI_CETP_C-2obdA02

A:226-463

Asymmetric/Biological Unit(hide GO term definitions)

Chain A (CETP_HUMAN | P11597)

molecular function
	GO:0015485	cholesterol binding	Interacting selectively and non-covalently with cholesterol (cholest-5-en-3-beta-ol); the principal sterol of vertebrates and the precursor of many steroids, including bile acids and steroid hormones.
	GO:0017127	cholesterol transporter activity	Enables the directed movement of cholesterol into, out of or within a cell, or between cells. Cholesterol is the principal sterol of vertebrates and the precursor of many steroids, including bile acids and steroid hormones.
	GO:0008289	lipid binding	Interacting selectively and non-covalently with a lipid.
	GO:0005319	lipid transporter activity	Enables the directed movement of lipids into, out of or within a cell, or between cells.
	GO:0031210	phosphatidylcholine binding	Interacting selectively and non-covalently with phosphatidylcholine, a class of glycophospholipids in which a phosphatidyl group is esterified to the hydroxyl group of choline.
	GO:0005548	phospholipid transporter activity	Enables the directed movement of phospholipids into, out of or within a cell, or between cells. Phospholipids are a class of lipids containing phosphoric acid as a mono- or diester.
	GO:0017129	triglyceride binding	Interacting selectively and non-covalently with any triester of glycerol.
biological process
	GO:0042632	cholesterol homeostasis	Any process involved in the maintenance of an internal steady state of cholesterol within an organism or cell.
	GO:0008203	cholesterol metabolic process	The chemical reactions and pathways involving cholesterol, cholest-5-en-3 beta-ol, the principal sterol of vertebrates and the precursor of many steroids, including bile acids and steroid hormones. It is a component of the plasma membrane lipid bilayer and of plasma lipoproteins and can be found in all animal tissues.
	GO:0030301	cholesterol transport	The directed movement of cholesterol, cholest-5-en-3-beta-ol, into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.
	GO:0034375	high-density lipoprotein particle remodeling	The acquisition, loss or modification of a protein or lipid within a high-density lipoprotein particle, including the hydrolysis of triglyceride by hepatic lipase, with the subsequent loss of free fatty acid, and the transfer of cholesterol esters from LDL to a triglyceride-rich lipoprotein particle by cholesteryl ester transfer protein (CETP), with the simultaneous transfer of triglyceride to LDL.
	GO:0055088	lipid homeostasis	Any process involved in the maintenance of an internal steady state of lipid within an organism or cell.
	GO:0006629	lipid metabolic process	The chemical reactions and pathways involving lipids, compounds soluble in an organic solvent but not, or sparingly, in an aqueous solvent. Includes fatty acids; neutral fats, other fatty-acid esters, and soaps; long-chain (fatty) alcohols and waxes; sphingoids and other long-chain bases; glycolipids, phospholipids and sphingolipids; and carotenes, polyprenols, sterols, terpenes and other isoprenoids.
	GO:0006869	lipid transport	The directed movement of lipids into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. Lipids are compounds soluble in an organic solvent but not, or sparingly, in an aqueous solvent.
	GO:0042157	lipoprotein metabolic process	The chemical reactions and pathways involving any conjugated, water-soluble protein in which the covalently attached nonprotein group consists of a lipid or lipids.
	GO:0034374	low-density lipoprotein particle remodeling	The acquisition, loss or modification of a protein or lipid within a low-density lipoprotein particle, including the hydrolysis of triglyceride by hepatic lipase, with the subsequent loss of free fatty acid, and the transfer of cholesterol esters from LDL to a triglyceride-rich lipoprotein particle by cholesteryl ester transfer protein (CETP), with the simultaneous transfer of triglyceride to LDL.
	GO:0010745	negative regulation of macrophage derived foam cell differentiation	Any process that decreases the rate, frequency or extent of macrophage derived foam cell differentiation. Macrophage derived foam cell differentiation is the process in which a macrophage acquires the specialized features of a foam cell. A foam cell is a type of cell containing lipids in small vacuoles and typically seen in atherosclerotic lesions, as well as other conditions.
	GO:0046470	phosphatidylcholine metabolic process	The chemical reactions and pathways involving phosphatidylcholines, any of a class of glycerophospholipids in which the phosphatidyl group is esterified to the hydroxyl group of choline. They are important constituents of cell membranes.
	GO:0055091	phospholipid homeostasis	Any process involved in the maintenance of an internal steady state of phospholipid within an organism or cell.
	GO:0015914	phospholipid transport	The directed movement of phospholipids into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. Phospholipids are any lipids containing phosphoric acid as a mono- or diester.
	GO:0006898	receptor-mediated endocytosis	An endocytosis process in which cell surface receptors ensure specificity of transport. A specific receptor on the cell surface binds tightly to the extracellular macromolecule (the ligand) that it recognizes; the plasma-membrane region containing the receptor-ligand complex then undergoes endocytosis, forming a transport vesicle containing the receptor-ligand complex and excluding most other plasma-membrane proteins. Receptor-mediated endocytosis generally occurs via clathrin-coated pits and vesicles.
	GO:0010874	regulation of cholesterol efflux	Any process that modulates the frequency, rate or extent of cholesterol efflux. Cholesterol efflux is the directed movement of cholesterol, cholest-5-en-3-beta-ol, out of a cell or organelle.
	GO:0043691	reverse cholesterol transport	The directed movement of peripheral cell cholesterol, cholest-5-en-3-beta-ol, towards the liver for catabolism.
	GO:0008202	steroid metabolic process	The chemical reactions and pathways involving steroids, compounds with a 1,2,cyclopentanoperhydrophenanthrene nucleus.
	GO:0006810	transport	The directed movement of substances (such as macromolecules, small molecules, ions) or cellular components (such as complexes and organelles) into, out of or within a cell, or between cells, or within a multicellular organism by means of some agent such as a transporter, pore or motor protein.
	GO:0070328	triglyceride homeostasis	Any process involved in the maintenance of an internal steady state of triglyceride within an organism or cell.
	GO:0006641	triglyceride metabolic process	The chemical reactions and pathways involving triglyceride, any triester of glycerol. The three fatty acid residues may all be the same or differ in any permutation. Triglycerides are important components of plant oils, animal fats and animal plasma lipoproteins.
	GO:0034197	triglyceride transport	The directed movement of triglyceride into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. Triglycerides are important components of plant oils, animal fats and animal plasma lipoproteins.
	GO:0034372	very-low-density lipoprotein particle remodeling	The acquisition, loss or modification of a protein or lipid within a very-low-density lipoprotein particle, including the hydrolysis of triglyceride by hepatic lipase or lipoprotein lipase and the subsequent loss of free fatty acid.
cellular component
	GO:0070062	extracellular exosome	A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm.
	GO:0005576	extracellular region	The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
	GO:0005615	extracellular space	That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
	GO:0034364	high-density lipoprotein particle	A lipoprotein particle with a high density (typically 1.063-1.21 g/ml) and a diameter of 5-10 nm that contains APOAs and may contain APOCs and APOE; found in blood and carries lipids from body tissues to the liver as part of the reverse cholesterol transport process.
	GO:0031982	vesicle	Any small, fluid-filled, spherical organelle enclosed by membrane.

Asymmetric/Biological Unit
	Complete Structure
		Jena3D(integrated viewing of ligand, site, SAP, PROSITE, SCOP information)
		WebMol \| AstexViewer[tm]@PDBe (Java Applets, require no local installation except for Java; loading may be slow)
		STRAP (Java WebStart application, automatic local installation, requires Java; full application with system access!)
		RasMol (require local installation)
		Molscript (VRML) (requires installation of a VRML viewer; select preferred view via VRML and generate a mono or stereo PDF format file)

	Ligands, Modified Residues, Ions
		1PE	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]
		2OB	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]
		CL	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]
		EPE	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]
		FU4	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]
		NDG	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]
		PCW	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]
		PG4	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]

	Sites
		AC1	[ RasMol ]	+environment [ RasMol ]
		AC2	[ RasMol ]	+environment [ RasMol ]
		AC3	[ RasMol ]	+environment [ RasMol ]
		AC4	[ RasMol ]	+environment [ RasMol ]
		AC5	[ RasMol ]	+environment [ RasMol ]
		AC6	[ RasMol ]	+environment [ RasMol ]
		AC7	[ RasMol ]	+environment [ RasMol ]
		AC8	[ RasMol ]	+environment [ RasMol ]
		AC9	[ RasMol ]	+environment [ RasMol ]
		BC1	[ RasMol ]	+environment [ RasMol ]
		BC2	[ RasMol ]	+environment [ RasMol ]
		BC3	[ RasMol ]	+environment [ RasMol ]

	Cis Peptide Bonds
		Val A:312 - Gly A:313	[ RasMol ]

Jmol
	protein: cartoon or spacefill or dots and stick; nucleic acid: cartoon and stick; ligands: spacefill; active site: stick [ Asym./Biol. Unit PNG format \| Asym./Biol. Unit - sites PNG format ](automatic orientation, automatically generated)
Molscript
	protein, nucleic acid: cartoon; ligands: spacefill; active site: ball and stick [ mono PDF format \| stereo PDF format ](default orientation, automatically generated)

Access by PDB/NDB ID
	2obd
		Family and Domain Information	:	ProDom \| SYSTERS
		General Structural Information	:	GlycoscienceDB \| MMDB \| NDB \| OCA \| PDB \| PDBe \| PDBj \| PDBsum \| PDBWiki \| PQS \| PROTEOPEDIA
		Orientation in Membranes	:	OPM
		Protein Surface	:	SURFACE
		Secondary Structure	:	DSSP (structure derived) \| HSSP (homology derived)
		Structural Genomics	:	GeneCensus
		Structural Neighbours	:	CE \| VAST
		Structure Classification	:	CATH \| Dali \| SCOP
		Validation and Original Data	:	BMRB Data View \| BMRB Restraints Grid \| EDS \| PROCHECK \| RECOORD \| WHAT_CHECK

Access by UniProt ID/Accession number
	CETP_HUMAN \| P11597
		Comparative Protein Structure Models	:	ModBase
		Genomic Information	:	Ensembl
		Protein-protein Interaction	:	DIP
		Sequence, Family and Domain Information	:	InterPro \| Pfam \| SMART \| UniProtKB/SwissProt

Access by Enzyme Classificator (EC Number)
	(no 'Enzyme Classificator' available)
		General Enzyme Information	:	BRENDA \| EC-PDB \| Enzyme \| IntEnz
		Pathway	:	KEGG \| MetaCyc

Access by Disease Identifier (MIM ID)
	143470
		Disease Information	:	OMIM

Access by GenAge ID
	(no 'GenAge ID' available)
		Age Related Information	:	GenAge

Access by PDB/NDB ID
		Domain Information	:	XDom
		Interatomic Contacts of Structural Units	:	CSU
		Ligand-protein Contacts	:	LPC
		Protein Cavities	:	castP
		Sequence and Secondary Structure	:	PDBCartoon
		Structure Alignment	:	STRAP(Java WebStart application, automatic local installation, requires Java; full application with system access!)
		Structure and Sequence Browser	:	STING

Access by UniProt ID/Accession number
	CETP_HUMAN \| P11597
		Protein Disorder Prediction	:	DisEMBL \| FoldIndex \| GLOBPLOT (for more information see DisProt)

UniProtKB/Swiss-Prot
	CETP_HUMAN \| P11597	:	4ews 4f2a

(no "Related Entries Specified in the PDB File" available for 2OBD)

Description

Compounds

Structural Features

Chains, Units

Ligands, Modified Residues, Ions (8, 12)

Sites (12, 12)

SS Bonds (1, 1)

Cis Peptide Bonds (1, 1)

Sequence-Structure Mapping

SAPs(SNPs)/Variants (11, 11)

PROSITE Motifs (1, 1)

Exons (16, 16)

Sequences/Alignments

Classification and Annotation

SCOP Domains (0, 0)

CATH Domains (0, 0)

Pfam Domains (2, 2)

Gene Ontology (34, 34)

Visualization

Interactive Views

Still Images

Databases and Analysis Tools

Databases

Analysis Tools

Related Entries

Entries Sharing at Least One Protein Chain (UniProt ID)

Related Entries Specified in the PDB File